null Option on Corvus Pharmaceuticals
| CRVS Stock | USD 5.29 0.21 4.13% |
Corvus Pharmaceuticals' latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 1.59 with a put-to-call open interest ratio of 1.37 over 35 outstanding agreements suggesting investors are buying more puts than calls on contracts expiring on April 17th 2025.
Open Interest Against April 17th 2025 Option Contracts
Corvus Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Corvus Pharmaceuticals' lending market. For example, when Corvus Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Corvus Pharmaceuticals, he or she must hedge the risk by shorting Corvus Pharmaceuticals stock over its option's life.
2025-04-17
The chart above shows Corvus Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Corvus Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Corvus Pharmaceuticals' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Corvus Pharmaceuticals
Analyzing Corvus Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Corvus Pharmaceuticals regardless of its overall volatility. This is especially true when Corvus Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Corvus Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Corvus Pharmaceuticals' stock while costing only a fraction of its price.
Corvus Pharmaceuticals In The Money Call Balance
When Corvus Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Corvus Pharmaceuticals stock is said to be in the money. When it comes to buying Corvus Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Corvus Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Corvus Current Options Market Mood
Corvus Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Corvus Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Corvus Pharmaceuticals' options investors are not very successful. Corvus Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Corvus contract
Base on the Rule 16, the options market is currently suggesting that Corvus Pharmaceuticals will have an average daily up or down price movement of about 0.0994% per day over the life of the 2025-04-17 option contract. With Corvus Pharmaceuticals trading at USD 5.29, that is roughly USD 0.005257. If you think that the market is fully incorporating Corvus Pharmaceuticals' daily price movement you should consider buying Corvus Pharmaceuticals options at the current volatility level of 1.59%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Corvus |
Purchasing Corvus Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Corvus calls. Remember, the seller must deliver Corvus Pharmaceuticals stock to the call owner when a call is exercised.
Corvus Pharmaceuticals Option Chain
When Corvus Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Corvus Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Corvus Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Corvus. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Corvus. It also shows strike prices and maturity days for a Corvus Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | CRVS250417C00002000 | 15 | 2.0 | 1.15 - 5.8 | 2.83 | In |
Call | CRVS250417C00003000 | 16 | 3.0 | 2.2 - 2.8 | 2.75 | In |
Call | CRVS250417C00004000 | 108 | 4.0 | 1.7 - 2.05 | 1.8 | In |
Call | CRVS250417C00005000 | 118 | 5.0 | 1.25 - 1.5 | 1.4 | In |
Call | CRVS250417C00006000 | 241 | 6.0 | 0.9 - 1.15 | 1.1 | Out |
Call | CRVS250417C00007000 | 108 | 7.0 | 0.65 - 0.95 | 0.77 | Out |
Call | CRVS250417C00008000 | 526 | 8.0 | 0.45 - 0.75 | 0.6 | Out |
Call | CRVS250417C00009000 | 1321 | 9.0 | 0.25 - 0.6 | 0.5 | Out |
Call | CRVS250417C00010000 | 85 | 10.0 | 0.05 - 0.7 | 1.22 | Out |
Call | CRVS250417C00011000 | 115 | 11.0 | 0.2 - 0.4 | 0.05 | Out |
Call | CRVS250417C00012000 | 2002 | 12.0 | 0.0 - 0.55 | 0.3 | Out |
Call | CRVS250417C00013000 | 23 | 13.0 | 0.0 - 4.8 | 2.18 | Out |
Call | CRVS250417C00014000 | 0 | 14.0 | 0.0 - 0.3 | 0.3 | |
Call | CRVS250417C00015000 | 0 | 15.0 | 0.0 - 4.8 | 4.8 | |
Call | CRVS250417C00016000 | 4 | 16.0 | 0.0 - 0.2 | 1.5 | Out |
Call | CRVS250417C00017000 | 91 | 17.0 | 0.05 - 0.25 | 0.1 | Out |
Call | CRVS250417C00018000 | 43 | 18.0 | 0.0 - 0.25 | 0.25 | Out |
Put | CRVS250417P00001000 | 1 | 1.0 | 0.0 - 0.05 | 0.1 | Out |
Put | CRVS250417P00002000 | 135 | 2.0 | 0.0 - 4.8 | 0.25 | Out |
Put | CRVS250417P00003000 | 6 | 3.0 | 0.0 - 1.05 | 0.35 | Out |
Put | CRVS250417P00004000 | 71 | 4.0 | 0.4 - 0.7 | 0.6 | Out |
Put | CRVS250417P00005000 | 2005 | 5.0 | 0.0 - 1.55 | 1.04 | Out |
Put | CRVS250417P00006000 | 213 | 6.0 | 1.55 - 1.85 | 1.97 | In |
Put | CRVS250417P00007000 | 18 | 7.0 | 2.3 - 2.8 | 2.75 | In |
Put | CRVS250417P00008000 | 13 | 8.0 | 3.1 - 3.4 | 4.0 | In |
Put | CRVS250417P00009000 | 4027 | 9.0 | 3.7 - 4.7 | 3.99 | In |
Put | CRVS250417P00010000 | 48 | 10.0 | 4.7 - 5.2 | 4.77 | In |
Put | CRVS250417P00011000 | 63 | 11.0 | 5.6 - 6.1 | 5.1 | In |
Put | CRVS250417P00012000 | 5 | 12.0 | 6.5 - 7.2 | 5.9 | In |
Put | CRVS250417P00013000 | 12 | 13.0 | 7.7 - 8.1 | 6.9 | In |
Put | CRVS250417P00014000 | 1 | 14.0 | 8.3 - 9.6 | 7.84 | In |
Put | CRVS250417P00015000 | 0 | 15.0 | 9.1 - 10.3 | 9.1 | In |
Put | CRVS250417P00016000 | 0 | 16.0 | 9.8 - 11.4 | 9.8 | In |
Put | CRVS250417P00017000 | 0 | 17.0 | 10.5 - 12.3 | 10.5 | In |
Put | CRVS250417P00018000 | 0 | 18.0 | 11.7 - 13.3 | 11.7 | In |
Corvus Pharmaceuticals Market Cap Over Time
Market Cap |
| Timeline |
Corvus Total Stockholder Equity
Total Stockholder Equity |
|
Corvus Pharmaceuticals Corporate Management
| Leiv Lea | Chief Officer | Profile | |
| James MD | Senior Research | Profile | |
| Alan Esq | Sec | Profile | |
| MD FACP | CoFounder Director | Profile | |
| Jeffrey Arcara | Chief Officer | Profile |
Additional Tools for Corvus Stock Analysis
When running Corvus Pharmaceuticals' price analysis, check to measure Corvus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corvus Pharmaceuticals is operating at the current time. Most of Corvus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Corvus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corvus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Corvus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.